Zobrazeno 1 - 10
of 336
pro vyhledávání: '"W.M. Johnson"'
Autor:
Tim M. Illidge, Elizabeth H. Phillips, Nicholas Counsell, Ruth Pettengell, Peter W.M. Johnson, Dominic J. Culligan, Bilyana Popova, Laura Clifton-Hadley, Andrew McMillan, Peter Hoskin, Sally F. Barrington, John Radford
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 203-206 (2020)
Externí odkaz:
https://doaj.org/article/22a017ba18324963a873caf2b7ad3390
Autor:
Andrew J. Steele, Jan A. Burger, Greg P. Coffey, Francesco Forconi, Graham Packham, Freda K. Stevenson, Jonathan C. Strefford, Anjali Pandey, Pamela B. Conley, Peter W.M. Johnson, Andrew Davies, Lindsay D. Smith, Jack Parnell, Alice Hayman, Sarah Wilmore, Marta Larrayoz, Rachel C. Dobson, Stefan Koehrer, Matthew D. Blunt
Supplementary methods and Figures Supplementary Figure 1. Effect of cerdulatinib on Immobilised anti-IgM mediated signaling Supplementary Figure 2. Effect of cerdulatinib on soluble anti-IgM mediated signaling Supplementary Figure 3. Effect of cerdul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a468e825532cc2770eba48a39c5394f7
https://doi.org/10.1158/1078-0432.22463541
https://doi.org/10.1158/1078-0432.22463541
Autor:
Andrew J. Steele, Jan A. Burger, Greg P. Coffey, Francesco Forconi, Graham Packham, Freda K. Stevenson, Jonathan C. Strefford, Anjali Pandey, Pamela B. Conley, Peter W.M. Johnson, Andrew Davies, Lindsay D. Smith, Jack Parnell, Alice Hayman, Sarah Wilmore, Marta Larrayoz, Rachel C. Dobson, Stefan Koehrer, Matthew D. Blunt
Purpose: B-cell receptor (BCR)–associated kinase inhibitors, such as ibrutinib, have revolutionized the treatment of chronic lymphocytic leukemia (CLL). However, these agents are not curative, and resistance is already emerging in a proportion of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65982893f3a24771c803dc31b3ed3e60
https://doi.org/10.1158/1078-0432.c.6525432
https://doi.org/10.1158/1078-0432.c.6525432
Autor:
Andrew J. Davies, Sharon Barrans, Louise Stanton, Josh Caddy, Sam Wilding, Geoff Saunders, Christoph Mamot, Urban Novak, Andrew McMillan, Paul Fields, Graham P. Collins, Richard Stephens, Francesco Cucco, Chulin Sha, Moniek van Hoppe, Reuben Tooze, John R. Davies, Gareth Griffiths, Anna Schuh, Catherine Burton, David R. Westhead, Ming-Qing Du, Peter W.M. Johnson
Publikováno v:
Davies, Andrew J; Barrans, Sharon; Stanton, Louise; Caddy, Josh; Wilding, Sam; Saunders, Geoff; Mamot, Christoph; Novak, Urban; McMillan, Andrew; Fields, Paul; Collins, Graham P; Stephens, Richard; Cucco, Francesco; Sha, Chulin; van Hoppe, Moniek; Tooze, Reuben; Davies, John R; Griffiths, Gareth; Schuh, Anna; Burton, Catherine; ... (2023). Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(15), pp. 2718-2723. American Society of Clinical Oncology 10.1200/JCO.23.00033
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6393d74e85b1c2b6a31b21155d2ee789
Autor:
Simon Rule, Paul Smith, Peter W.M. Johnson, Simon Bolam, George Follows, Joanne Gambell, Peter Hillmen, Andrew Jack, Stephen Johnson, Amy A Kirkwood, Anton Kruger, Christopher Pocock, John F. Seymour, Milena Toncheva, Jan Walewski, David Linch
Publikováno v:
Haematologica, Vol 101, Iss 2 (2016)
Mantle cell lymphoma is an incurable and generally aggressive lymphoma that is more common in elderly patients. Whilst a number of different chemotherapeutic regimens are active in this disease, there is no established gold standard therapy. Rituxima
Externí odkaz:
https://doaj.org/article/f337005569d54ae79221956560b278ff
Autor:
Sean H. Lim, Nicola Campbell, Beth Stuart, Marina Johnson, Debora Joseph-Pietras, Adam Kelly, Danielle Jeffrey, Anna H. Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O’Callaghan, Graham P. Collins, Tobias Menne, Saul N. Faust, Christopher P. Fox, Matthew Ahearne, Peter W.M. Johnson, Andrew J. Davies, David Goldblatt
SUMMARYSARS-CoV-2 vaccination protects against COVID-19. Antibodies and antigen-specific T-cell responses against the spike domain can be used to measure vaccine immune response. Individuals with lymphoma have defects in humoral and cellular immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05db81c23d3f376117b26a44fb620057
https://doi.org/10.1101/2021.12.08.21266760
https://doi.org/10.1101/2021.12.08.21266760
Autor:
Ruth H. Keogh, Nazmus Haq, Karla Diaz-Ordaz, Andrew Hayward, Julia Hippisley-Cox, Malcolm G Semple, Peter W.M. Johnson, Peter Sellen, Ewen M Harrison, Nisha Mehta, Ronan A Lyons, Jonathan S. Nguyen-Van-Tam, Carol Coupland, Shamim Rahman, Jonathan Valabhji, Aziz Sheikh, Frank Kee, Kamlesh Khunti
Publikováno v:
Hippisley-Cox, J, Coupland, C A, Mehta, N, Keogh, R H, Diaz-Ordaz, K, Khunti, K, Lyons, R A, Kee, F, Sheikh, A, Rahman, S, Valabhji, J, Harrison, E M, Sellen, P, Haq, N, Semple, M G, Johnson, P W M, Hayward, A & Nguyen-Van-Tam, J S 2021, ' Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study ', BMJ, vol. 374, n2244 . https://doi.org/10.1136/bmj.n2244
The BMJ
Hippisley-Cox, J, Coupland, C A C, Mehta, N, Keogh, R H, Diaz-Ordaz, K, Khunti, K, Lyons, R A, Kee, F, Sheikh, A, Rahman, S, Valabhji, J, Harrison, E M, Sellen, P, Haq, N, Semple, M G, Johnson, P WM, Hayward, A & Nguyen-Van-Tam, J S 2021, ' Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination : national prospective cohort study ', British Medical Journal (BMJ), vol. 374, 2244 . https://doi.org/10.1136/bmj.n2244 (
The BMJ
Hippisley-Cox, J, Coupland, C A C, Mehta, N, Keogh, R H, Diaz-Ordaz, K, Khunti, K, Lyons, R A, Kee, F, Sheikh, A, Rahman, S, Valabhji, J, Harrison, E M, Sellen, P, Haq, N, Semple, M G, Johnson, P WM, Hayward, A & Nguyen-Van-Tam, J S 2021, ' Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination : national prospective cohort study ', British Medical Journal (BMJ), vol. 374, 2244 . https://doi.org/10.1136/bmj.n2244 (
Objectives To derive and validate risk prediction algorithms to estimate the risk of covid-19 related mortality and hospital admission in UK adults after one or two doses of covid-19 vaccination. Design Prospective, population based cohort study usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ccd4b11cb1bb7653c46f2ec8a75dab8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sean H. Lim, Stephen A. Beers, Ruth R. French, Peter W.M. Johnson, Martin J. Glennie, Mark S. Cragg
Publikováno v:
Haematologica, Vol 95, Iss 1 (2010)
Antibodies to CD20 have confirmed the hypothesis that monoclonal reagents can be given in vivo to alleviate human diseases. The targeting of CD20 on normal, malignant and auto-immune B-lymphocytes by rituximab has demonstrated substantial benefits fo
Externí odkaz:
https://doaj.org/article/45be2e1b10ec43398c169e74178390fe